QuantuMDx Group Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:QuantuMDx Group Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12341
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
QuantuMDx Group Ltd (QuantuMDx) is a developer of sciences tools and diagnostics products. The company’s products include Q-POC, a handheld DNA analyzer that provides an accurate molecular diagnostic results. It develops assays for diagnosis and drug susceptibility testing of infectious diseases, and companion diagnostics assays and tumour profiling. QuantuMDx also develops technologies such as Q-PREP, Q-AMP, Q-DETECT and Q-SEQ. The company’s devices are built using a range of complex technologies such as nanowires, microfluidic technologies and molecular biology technology. It serves clinics, pharmacies, hospitals and labs. The company has operations in the US and Singapore. QuantuMDx is headquartered in Newcastle Upon Tyne, the UK.

QuantuMDx Group Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
QuantuMDx Group Ltd, Medical Devices Deals, 2012 to YTD 2018 9
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
QuantuMDx Raises USD8.4 Million in Venture Financing 11
Partnerships 12
Foundation for Innovative New Diagnostics Enters into Agreement with QuantuMDx 12
Equity Offering 13
QuantuMDx Plans IPO 13
QuantuMDx Group Ltd – Key Competitors 14
QuantuMDx Group Ltd – Key Employees 15
QuantuMDx Group Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Corporate Communications 17
Sep 12, 2018: QuantuMDx announces senior management changes 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
QuantuMDx Group Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
QuantuMDx Group Ltd, Medical Devices Deals, 2012 to YTD 2018 9
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
QuantuMDx Raises USD8.4 Million in Venture Financing 11
Foundation for Innovative New Diagnostics Enters into Agreement with QuantuMDx 12
QuantuMDx Plans IPO 13
QuantuMDx Group Ltd, Key Competitors 14
QuantuMDx Group Ltd, Key Employees 15
QuantuMDx Group Ltd, Other Locations 16
QuantuMDx Group Ltd, Subsidiaries 16

List of Figures
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
QuantuMDx Group Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[QuantuMDx Group Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • UTC Engenharia SA:企業の戦略的SWOT分析
    UTC Engenharia SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • China Taiping Insurance Holdings Company Limited:戦略・SWOT・企業財務分析
    China Taiping Insurance Holdings Company Limited - Strategy, SWOT and Corporate Finance Report Summary China Taiping Insurance Holdings Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Evelo Biosciences Inc (EVLO):製薬・医療:M&Aディール及び事業提携情報
    Summary Evelo Biosciences Inc (Evelo Biosciences), formerly Evelo Therapeutics Inc is a clinical stage biotechnology company. It focuses on the development of novel medicines designed to act on immune cells in the gut-body network for the treatment of inflammatory diseases and cancer. The company's …
  • Pfizer Inc.:企業のM&A・事業提携・投資動向
    Pfizer Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pfizer Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Nectar Lifesciences Ltd (NECLIFE):企業の財務・戦略的SWOT分析
    Summary Nectar Lifesciences Ltd (NecLife) is a research driven pharmaceutical company that manufactures active pharmaceutical ingredients (APIs). The company provides contract research and manufacturing services such as process development and optimization, process scale up and validation, multi kil …
  • The Hearst Corporation:企業の戦略的SWOT分析
    The Hearst Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Standard Chartered Plc:企業の戦略・SWOT・財務情報
    Standard Chartered Plc - Strategy, SWOT and Corporate Finance Report Summary Standard Chartered Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Casual Dining Group Ltd.:企業の戦略・SWOT・財務情報
    Casual Dining Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Casual Dining Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • OUE Ltd:戦略・SWOT・企業財務分析
    OUE Ltd - Strategy, SWOT and Corporate Finance Report Summary OUE Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Saudi Industrial Export Company (4140):企業の財務・戦略的SWOT分析
    Summary Saudi Industrial Export Company (SIEC) is a chemical providing company that imports, exports and selss specialty chemicals, fertilizers, industrial materials and commodities. The company's fertilizers include diammonium phosphate, sulphur, urea, triple super phosphate, granular triple super …
  • CITIC Resources Holdings Limited:戦略・SWOT・企業財務分析
    CITIC Resources Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary CITIC Resources Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • DST Systems, Inc.:企業の戦略・SWOT・財務情報
    DST Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary DST Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Veolia Environnement S.A.:企業の戦略・SWOT・財務分析
    Veolia Environnement S.A. - Strategy, SWOT and Corporate Finance Report Summary Veolia Environnement S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Snowy Hydro Ltd:企業の戦略的SWOT分析
    Snowy Hydro Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Vstecs Holdings Ltd:企業の戦略・SWOT・財務分析
    Vstecs Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Vstecs Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • ShawCor Ltd (SCL):企業の財務・戦略的SWOT分析
    ShawCor Ltd (SCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • OGK-2 (OGKB):企業の財務・戦略的SWOT分析
    OGK-2 (OGKB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Vericel Corp (VCEL):企業の財務・戦略的SWOT分析
    Vericel Corp (VCEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Protea Biosciences Group Inc (PRGB):企業の財務・戦略的SWOT分析
    Summary Protea Biosciences Group Inc (Protea) operates as a biotechnology company that develops mass spectometry solutions. The company offers technology for identification, characterization, and quantitation of biologically-important molecules for pharmaceutical development, research, and diagnosti …
  • Telkom SA SOC Limited (TKG):企業の財務・戦略的SWOT分析
    Telkom SA SOC Limited (TKG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆